表紙
市場調查報告書
商品編碼
1028857

全球免疫療法藥市場報告:2021年版 - COVID-19擴大和2030年的變化

Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth And Change To 2030

出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球免疫療法藥市場相關調查,網羅市場特性,規模與成長,市場區隔,各地各國趨勢,競爭情形,市場佔有率,市場趨勢與策略。還有各地區的市場的實際成果與預測,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 免疫療法藥市場特徵

第3章 免疫療法藥市場趨勢與策略

第4章 COVID-19對免疫療法藥的影響

第5章 免疫療法藥的市場規模與成長

  • 全球免疫療法藥市場實際成果,2015∼2020年,10億美元
    • 市場促進因素
    • 市場阻礙因素
  • 全球免疫療法藥市場預測,2020∼2025年,2030年,10億美元
    • 市場促進因素
    • 市場阻礙因素

第6章 免疫療法藥市場細分化

  • 全球免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 單株抗體
  • 干擾素
  • 白細胞介素
  • 疫苗
  • 查核點抑制劑
  • 其他
  • 全球免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 癌症
  • 自體免疫及發炎性疾病
  • 感染疾病
  • 其他
  • 全球免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 醫院·診所
  • 門診病人手術中心
  • 其他

第7章 免疫療法藥市場各地區以及各國分析

  • 全球免疫療法藥市場,各地區,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 全球免疫療法藥市場,各國,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第8章 亞太地區的免疫療法藥市場

  • 亞太地區的免疫療法藥市場概要
  • 地區資訊,COVID-19的影響,市場資訊,背景資訊,政府的積極推動,法規,法規機關,主要的協會,免稅,公司稅結構,投資,主要企業
  • 亞太地區的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 亞太地區的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 亞太地區的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第9章 中國的免疫療法藥市場

  • 免疫療法市場概要的中國的藥
  • 中國的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中國的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中國的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第10章 印度的免疫療法藥市場

  • 印度的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印度的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印度的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第11章 日本的免疫療法藥市場

  • 日本的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 日本的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 日本的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第12章 澳洲的免疫療法藥市場

  • 澳洲的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 澳洲的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 澳洲的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第13章 印尼的免疫療法藥市場

  • 印尼的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印尼的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 印尼的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第14章 韓國的免疫療法藥市場

  • 韓國的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 韓國的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 韓國的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第15章 西歐的免疫療法藥市場

  • 西歐的免疫療法藥市場概要
  • 西歐的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 西歐的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 西歐的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第16章 英國的免疫療法藥市場

  • 英國的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 英國的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 英國的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第17章 德國的免疫療法藥市場

  • 德國的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 德國的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 德國的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第18章 法國的免疫療法藥市場

  • 法國的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 法國的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 法國的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第19章 東歐的免疫療法藥市場場

  • 東歐的免疫療法藥市場概要
  • 東歐的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 東歐的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 東歐的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第20章 俄羅斯的免疫療法藥市場

  • 俄羅斯的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 俄羅斯的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 俄羅斯的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第21章 北美的免疫療法藥市場

  • 北美的免疫療法藥市場概要
  • 北美的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 北美的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 北美的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第22章 美國的免疫療法藥市場

  • 美國的免疫療法藥市場概要
  • 美國的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 美國的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 美國的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第23章 南美的免疫療法藥市場

  • 南美的免疫療法藥市場概要
  • 南美的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 南美的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 南美的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第24章 巴西的免疫療法藥市場

  • 巴西的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 巴西的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 巴西的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第25章 中東的免疫療法藥市場

  • 中東的免疫療法藥市場概要
  • 中東的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中東的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 中東的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第26章 非洲的免疫療法藥市場

  • 非洲的免疫療法藥市場概要
  • 非洲的免疫療法藥市場,各類型市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 非洲的免疫療法藥市場,各治療領域市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元
  • 非洲的免疫療法藥市場,各終端用戶市場區隔,實際成果與預測,2015∼2020年,2020∼2025年,2030年,10億美元

第27章 免疫療法藥市場競爭情形和企業簡介概要

  • 免疫療法藥市場競爭情形
  • 免疫療法藥市場企業簡介概要
    • F. Hoffmann-La Roche Ltd
    • Novartis AG
    • Amgen, Inc
    • AbbVie, Inc
    • Merck & Co., Inc

第28章 免疫療法藥開發平台分析

第29章 免疫療法藥市場主要合併和收購

第30章 免疫療法藥市場未來展望和潛在性分析

第31章 附錄

目錄
Product Code: h881

Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global drugs for immunotherapy market.

The report focuses on the drugs for immunotherapy market which is experiencing strong growth. The report gives a guide to the drugs for immunotherapy market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the drugs for immunotherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs for Immunotherapy Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Monoclonal Antibodies; Interferons; Interleukins; Vaccines; Checkpoint Inhibitors; Others

2) By Therapy Area: Cancer; Autoimmune & Inflammatory Diseases; Infectious Diseases; Others

3) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Others

Companies Mentioned: F. Hoffmann-La Roche Ltd; Novartis AG; Amgen; AbbVie; Merck & Co.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Drugs for Immunotherapy Market Characteristics

3. Drugs for Immunotherapy Market Trends And Strategies

4. Impact Of COVID-19 On Drugs for Immunotherapy

5. Drugs for Immunotherapy Market Size And Growth

  • 5.1. Global Drugs for Immunotherapy Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Drugs for Immunotherapy Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Drugs for Immunotherapy Market Segmentation

  • 6.1. Global Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Monoclonal antibodies
  • Interferons
  • Interleukins
  • Vaccines
  • Checkpoint Inhibitors
  • Others
  • 6.2. Global Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cancer
  • Autoimmune & Inflammatory Diseases
  • Infectious Diseases
  • Others
  • 6.3. Global Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

7. Drugs for Immunotherapy Market Regional And Country Analysis

  • 7.1. Global Drugs for Immunotherapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Drugs for Immunotherapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Drugs for Immunotherapy Market

  • 8.1. Asia-Pacific Drugs for Immunotherapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.4. Asia-Pacific Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Drugs for Immunotherapy Market

  • 9.1. China Drugs for Immunotherapy Market Overview
  • 9.2. China Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.4. China Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Drugs for Immunotherapy Market

  • 10.1. India Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.3. India Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Drugs for Immunotherapy Market

  • 11.1. Japan Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.3. Japan Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Drugs for Immunotherapy Market

  • 12.1. Australia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.3. Australia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Drugs for Immunotherapy Market

  • 13.1. Indonesia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.3. Indonesia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Drugs for Immunotherapy Market

  • 14.1. South Korea Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.3. South Korea Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Drugs for Immunotherapy Market

  • 15.1. Western Europe Drugs for Immunotherapy Market Overview
  • 15.2. Western Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.4. Western Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Drugs for Immunotherapy Market

  • 16.1. UK Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.3. UK Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Drugs for Immunotherapy Market

  • 17.1. Germany Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.3. Germany Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Drugs for Immunotherapy Market

  • 18.5. France Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.6. France Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.7. France Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Drugs for Immunotherapy Market

  • 19.1. Eastern Europe Drugs for Immunotherapy Market Overview
  • 19.2. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.4. Eastern Europe Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Drugs for Immunotherapy Market

  • 20.1. Russia Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.3. Russia Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Drugs for Immunotherapy Market

  • 21.1. North America Drugs for Immunotherapy Market Overview
  • 21.2. North America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.4. North America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Drugs for Immunotherapy Market

  • 22.1. USA Drugs for Immunotherapy Market Overview
  • 22.2. USA Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.4. USA Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Drugs for Immunotherapy Market

  • 23.1. South America Drugs for Immunotherapy Market Overview
  • 23.2. South America Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.4. South America Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Drugs for Immunotherapy Market

  • 24.1. Brazil Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.3. Brazil Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Drugs for Immunotherapy Market

  • 25.1. Middle East Drugs for Immunotherapy Market Overview
  • 25.2. Middle East Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.4. Middle East Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Drugs for Immunotherapy Market

  • 26.1. Africa Drugs for Immunotherapy Market Overview
  • 26.2. Africa Drugs for Immunotherapy Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Drugs for Immunotherapy Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.4. Africa Drugs for Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Drugs for Immunotherapy Market Competitive Landscape And Company Profiles

  • 27.1. Drugs for Immunotherapy Market Competitive Landscape
  • 27.2. Drugs for Immunotherapy Market Company Profiles
    • 27.2.1. F. Hoffmann-La Roche Ltd
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Novartis AG
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Amgen, Inc
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. AbbVie, Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Merck & Co., Inc
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Drugs for Immunotherapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Drugs for Immunotherapy Market

30. Drugs for Immunotherapy Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer